Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; fertility; proton-pump inhibitors; semen quality;
مقالات ISI عارضه ناخواسته دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عارضه ناخواسته دارویی; Antipsychotic; Elderly; Death; Mortality; Adverse drug reaction; Dementia;
Keywords: عارضه ناخواسته دارویی; Adverse Drug Reaction; Costs; Frequency; Methods; Monitoring; Preventability; Severity; Tertiary care hospital; Types;
Keywords: عارضه ناخواسته دارویی; Drug-target interaction; Drug safety; Adverse drug reaction; Pharmacogenomic;
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; AHA; American Heart Association; ALT; alanine transaminase; AST; aspartate transaminase; BCG; Bacillus Calmette, Guérin (vaccine); CAAs; coronary artery aneurysms; CMRA; cardiac magnetic resonance angiography; CRP; C-reactive
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; drug-induced liver injury; hepatotoxicity; human leukocyte antigen; pharmacogenetics
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Drug-induced hypersensitivity; Drug-induced lymphocyte stimulation test; Tuberculosis
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; HED; Herbal medicine; NOAEL safety;
Keywords: عارضه ناخواسته دارویی; adverse drug reaction; dermatology; emergency; erythroderma; infection
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Animal toxicity; Medicine; Syncope; Seizure;
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; FDA boxed warning; Black box warning; Connectivity Map; Risk score model;
Keywords: عارضه ناخواسته دارویی; Herbal products; Adverse drug reaction; System organ class; Pharmacovigilance Programme of India; National Coordination Centre; VigiFlow
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Causative drugs; Serious reactions; Preventable reactions; Drug interactions
Keywords: عارضه ناخواسته دارویی; depression; drug; adverse drug reaction; case/non case study; dépression; médicament; effet indésirable; étude cas/non cas; ADR; adverse drug report; ADRs; adverse drug reactions; CI; confidence interval; CNS; central nervous system; FDA; Food and Dru
Keywords: عارضه ناخواسته دارویی; Pharmacovigilance; Adverse Drug Reaction; Quality deviation; Spontaneous report
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Drug related admission; Hospital admission; PubMed; Systemic review
Keywords: عارضه ناخواسته دارویی; Drug hypersensitivity; HLA; genetic polymorphisms; mechanisms; crystallography; ADR; Adverse drug reaction; p-i; Pharmacologic interaction; SJS; Stevens-Johnson syndrome; TEN; Toxic epidermal necrolysis;
Keywords: عارضه ناخواسته دارویی; Epidermal growth factor inhibitors; Monoclonal antibodies (cetuximab, panitumumab); Adverse drug reaction; Rash; Clinical markers; Tumor responseInhibidores del factor de crecimiento epidérmico; Anticuerpos monoclonales (cetuximab, panitumumab); Reacción
Keywords: عارضه ناخواسته دارویی; Tyrosine kinase inhibitors; Drug transporter; Drug interaction; Therapeutic drug monitoring; Skin disorders; ADR; Adverse drug reaction; AUC; Area under the curve; BBB; Blood-brain barrier; BCRP/ABCG2; Breast cancer resistance protein; CNS; Central nerv
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Pharmacovigilance; Social media;
Keywords: عارضه ناخواسته دارویی; Pharmacovigilance; Adverse drug reaction; Social media monitoring; Text classification; Natural language processing;
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; allergy; cephalosporin; Clostridium difficile; death; hemolytic anemia; hospitalized; oral; outpatient; nephropathy; parenteral; serious cutaneous adverse reaction; Stevens-Johnson syndrome; ADR; Adverse drug reaction; EHR; Electron
Keywords: عارضه ناخواسته دارویی; ACEi; angiotensin-converting enzyme inhibitor; ADR; adverse drug reaction; CCB; calcium channel blocker; CKD; chronic kidney disease; CNI; calcineurin inhibitor; eGFR; estimated glomerular filtration rate; GFR; glomerular filtration rate; NSAID; nonsteroi
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; AGREE; Appraisal of Guidelines for Research and Evaluation; DBP; diastolic blood pressure; FDA; Food and Drug Administration; GWAS; genome-wide association study; MAP; mean arterial pressure; MI; myocardial infarction; NA; not
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; bcell; biliary cell; BSA; bovine serum albumin; Ccell; concentration in cell lysate; Cmax; human therapeutic peak plasma concentration; Cmed; concentration in assay medium; CV; coefficient of variation; CYP; cytochrome P450; DM
Keywords: عارضه ناخواسته دارویی; Gold standard; Clinical text; Adverse drug reaction; Text mining;
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Matched case–control data; Multi-sample model; Reference sample; Source population; Spontaneous reporting database; Under-reporting
Keywords: عارضه ناخواسته دارویی; CYP; cytochrome P-450; GSH-transferase; glutathione-S-transferase; UDP-glucuronosyltransferase; uridine 5â²-diphospho-glucuronosyltransferase; EGb761®; Ginkgo biloba extract, CAS 122933-57-7; AhR; aryl hydrocarbon receptor; PXR; pregnane X receptor; CAR
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Drug–drug interaction; Elderly
Keywords: عارضه ناخواسته دارویی; Cisplatin; Hearing loss; Adverse drug reaction; Mexican children; Childhood cancer
Keywords: عارضه ناخواسته دارویی; Adverse drug event; adverse drug reaction; drug reaction classification; drug reaction mechanism; Medicines and Healthcare products Regulatory Agency
Keywords: عارضه ناخواسته دارویی; Prostate; Benign prostatic hyperplasia; Finasteride; Adverse drug reaction; Efficiency;
Keywords: عارضه ناخواسته دارویی; adverse drug reactions; spontaneous reporting; online reporting; :; effet indésirable médicamenteux; notification spontanée; déclaration électronique; ADR; adverse drug reaction; ATC; anatomical therapeutical chemical code; FPVD; French pharmacovigil
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; AE; adverse event; AML; acute myeloid leukemia; ALL; acute lymphoblastic leukemia; APL; acute promyelocytic leukemia; APTT; activated partial thromboplastin time; AT; antithrombin; CLL; chronic lymphocytic leukemia; CML; chroni
Keywords: عارضه ناخواسته دارویی; Anaphylaxis; Hypertensively reaction; Nonsteroidal anti-inflammatory drugs; Adverse drug reaction; Epinephrine; IgE mediated; ADR; Adverse drug reaction; ENDA; European Network on Drug Allergy; HSR; Hypersensitivity drug reaction; ICU; Intensive care unit
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Antituberculosis drug; Drug-induced liver injury; Liver function test
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; ALS; amyotrophic lateral sclerosis; COMET; Consortium for Metabonomic Toxicology; FTIR; Fourier transform infrared; GC; gas chromatography; H-D; hydrogen-deuterium; HMDB; Human Metabolomic Database; HPLC; high pressure liquid c
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; Oatp; organic anion transporting polypeptide; SNP; single nucleotide polymorphism; NASH; Non-alcoholic steatohepatitis; NAFLD; Non-alcoholic fatty liver disease; MCD; methionine and choline deficient; AUC; area under the curve;
Keywords: عارضه ناخواسته دارویی; Duloxetine; Antidepressant; SNRI; Serotonin toxicity; Adverse drug reaction; Sudden death;
Keywords: عارضه ناخواسته دارویی; Adverse drug reaction; Biclustering; Drug indication;
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; CAE; caraway aqueous extract; CBD; convention on biological diversity; CCDS; characteristic components data set; ESI; electrospray ionization; GC; gas chromatography; HPLC; high performance liquid chromatography; LC-IT-TOF-MS;
Keywords: عارضه ناخواسته دارویی; ACS; acute coronary syndrome; ADP; adenosine diphosphate; ADR; adverse drug reaction; CABG; coronary artery bypass surgery; CI; confidence interval; CV; cardiovascular; CYP; cytochrome p450; HOPR; high on-treatment platelet reactivity; HR; hazard ratio; H
Keywords: عارضه ناخواسته دارویی; Intravenous iron; Adverse drug reaction; Hypersensitivity; Toxicity;
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; ALL; acute lymphoblastic leukemia; BPD; bronchopulmonary dysplasia; DEX; dexamethasone; HL; Hodgkin lymphoma; RCT; randomized controlled trial;
Keywords: عارضه ناخواسته دارویی; Pharmacovigilance; Paediatrics; Adverse drug reaction; Underreporting;
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; CRP; C reactive protein; HSR; hypersensitivity syndrome reaction; IFN; interferon; IL; interleukin; SPD; sec-Butyl-propylacetamide; TNF; tumor necrosis factor; VCD; valnoctamide; VPA; valproic acid; SD; standard deviation; SE;
Keywords: عارضه ناخواسته دارویی; ADE; Adverse drug event; ADR; Adverse drug reaction; ADRE; Adverse drug-related event; CNS; Central nervous system; ED; Emergency department; ICU; Intensive care unit;
Keywords: عارضه ناخواسته دارویی; corticosteroid; drug hypersensitivity; drug-induced liver injury; ADR; adverse drug reaction; ALT; alanine aminotransferase; AST; aspartate aminotransferase; DiHS; drug-induced hypersensitivity syndrome; DRESS; drug reaction with eosinophilia and systemic
Keywords: عارضه ناخواسته دارویی; ADR; adverse drug reaction; AED; antiepileptic drug; AHS; Alpers-Huttenlocher syndrome; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; CYP; cytochrome p450; DRESS; drug reaction with eos
Keywords: عارضه ناخواسته دارویی; adverse drug reaction; drug-drug reaction; hyperkalemia; older adult; renin-angiotensin-aldosterone-system; trimethoprim-sulfamethoxazole; urinary tract infection